ATRC
AtriCure Inc
NASDAQ: ATRC · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$27.34
-4.00% today
Updated 2026-04-29
Market cap
$1.38B
P/E ratio
—
P/S ratio
2.59x
EPS (TTM)
$-0.24
Dividend yield
—
52W range
$27 – $43
Volume
0.7M
WallStSmart proprietary scores
37
out of 100
Grade: D
Sell
Investment rating
6.0
Growth
B7.3
Quality
B+2.5
Profitability
F5.7
Valuation
C+4/9
Piotroski F-Score
Moderate
2.2
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$46.75
+70.99%
12-Month target
—
—
Intrinsic (DCF)
$79.30
Margin of safety
+58.52%
3 Strong Buy3 Buy2 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $16.63M — positive
+ Revenue growth 13.10% QoQ
+ 58.52% below intrinsic value
Risks
- Thin margins at -2.14%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $330.38M | $399.25M | $465.31M | $534.53M | $534.53M |
| Net income | $-46.47M | $-30.44M | $-44.70M | $-11.45M | $1.76M |
| EPS | — | — | — | — | $-0.24 |
| Free cash flow | $-39.02M | $-37.51M | $-11.26M | $48.28M | $16.63M |
| Profit margin | -14.06% | -7.62% | -9.61% | -2.14% | -2.14% |
Peer comparison
Smart narrative
AtriCure Inc trades at $27.34. Our Smart Value Score of 37/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.18, it sits in the grey zone. TTM revenue stands at $534.53M. with profit margins at -2.14%. Our DCF model estimates intrinsic value at $79.30.
Frequently asked questions
What is AtriCure Inc's stock price?
AtriCure Inc (ATRC) trades at $27.34.
Is AtriCure Inc overvalued?
Smart Value Score 37/100 (Grade D, Sell). DCF value $79.30.
What is the price target of AtriCure Inc (ATRC)?
The analyst target price is $46.75, representing +71.0% upside from the current price of $27.34.
What is the intrinsic value of AtriCure Inc (ATRC)?
Based on our DCF model, intrinsic value is $79.30, a +58.5% margin of safety versus $27.34.
What is AtriCure Inc's revenue?
TTM revenue is $534.53M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
2.18 — grey zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.59x
ROE-2.40%
Beta1.43
50D MA$29.70
200D MA$34.62
Shares out0.05B
Float0.05B
Short ratio—
Avg volume0.7M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—